US Secretary of Health and Human Services (HHS) Kathleen Sebelius announced 4 new public-private collaborations to help people living with HIV get care for their illness and to help train clinicians to treat patients with the infection.The announcement came 3 days after HHS had announced an infusion of nearly $80 million to help low-income patients with the disease obtain medications and care.
- One effort, a partnership between HHS and the MAC AIDS Fund, will launch a mobile text-messaging pilot program called UCARE4LIFE to help patients with HIV infection adhere to strict medication regimens and to remain in care for the disease. The program involves developing a message library in English and Spanish for delivering timely reminders for medical appointments and for taking medications as prescribed.
- In another initiative intended to help patients adhere to HIV drug regimens and continue receiving care, the US Centers for Disease Control and Prevention will partner with a national pharmacy chain, Walgreens, to learn how pharmacies can play a role in this effort. The project will evaluate how well new collaborative agreements between clinicians and community pharmacists aimed at better drug therapy management and other supportive services achieve these goals and improve outcomes among patients with HIV infection.
- HHS is also joining with the 8 largest manufacturers of anti-HIV drugs to create a single application form (a sample form is available at http://hab.hrsa.gov/patientassistance/index.html) for AIDS medications offered through the companies’ patient-assistance programs, said Sebelius. Combination antiretroviral therapy often involves drugs made by different drug companies, and this single form will allow uninsured patients to apply for multiple assistance programs to obtain coverage for an entire course of antiretroviral therapy, regardless of manufacturer.
Good things are coming out of the Internationals AIDS Conference as you can see. Using technology to help with medications and stay in care which is critical.